Analgesic potential of intrathecal farnesyl thiosalicylic acid and GW 5074 in vincristine-induced neuropathic pain in rats

Food and Chemical Toxicology

Volumn 50, Issue 5, 2012, Pages 1295-1301

  Jaggi, Amteshwar Singh ^a   Singh, Nirmal ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Allodynia; Farnesyl thiosalicylic acid; GW 5074; Hyperalgesia; Vincristine

Indexed keywords

3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; RAF PROTEIN; RAS PROTEIN; SALIRASIB; VINCRISTINE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NEUROPATHY; RAT; SINGLE DRUG DOSE;

ANALGESICS; ANIMALS; FARNESOL; FEMALE; INDOLES; INJECTIONS, SPINAL; MALE; NEURALGIA; PHENOLS; RATS; RATS, WISTAR; SALICYLIC ACIDS; VINCRISTINE;

RATTUS;

EID: 84858246738     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.01.038     Document Type: Article

References (38)

1. Aizman E., Mor A., Chapman J., Assaf Y., Kloog Y. The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice. J. Neuroimmunol. 2010, 229:192-203.
2. Caspani O., Zurborg S., Labuz D., Heppenstall P.A. The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS One 2009, 4:e7383.
3. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 1994, 53:55-63.
4. Chen H.M., Wang L., D'Mello S.R. Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074. J. Neurochem. 2008, 105:1300-1312.
5. Chin P.C., Liu L., Morrison B.E., Siddiq A., Ratan R.R., Bottiglieri T., D' Mello S.R. The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism. J. Neurochem. 2004, 90:595-608.
6. Ciruela A., Dixon A.K., Bramwell S., Gonzalez M.I., Pinnock R.D., Lee K. Identification of MEK1 as a novel target for the treatment of neuropathic pain. Br. J. Pharmacol. 2003, 138:751-756.
7. Decosterd I., Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000, 87:149-158.
8. Echeverria V., Burgess S., Gamble-George J., Arendash G.W., Citron B.A. Raf inhibition protects cortical cells against beta-amyloid toxicity. Neurosci. Lett. 2008, 444:92-96.
9. Erichsen H.K., Blackburn-Munro G. Pharmacological characterization of the spared nerve injury model of neuropathic pain. Pain 2002, 98:151-161.
10. Frederick J., Buck M.E., Matson D.J., Cortright D.N. Increased TRPA1, TRPM8, and TRPV2 expression in dorsal root ganglia by nerve injury. Biochem. Biophys. Res. Commun. 2007, 358:1058-1064.
11. Haklai R., Weisz M.G., Elad G., Paz A., Marciano D., Egozi Y., BenBaruch G., Kloog Y. Dislodgment and accelerated degradation of Ras. Biochemistry 1998, 37:1306-1314.
12. Jaggi A.S., Singh N. Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats. Eur. J. Pharmacol. 2010, 648:102-109.
13. Jaggi A.S., Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology 2012, 291:1-9.
14. Kafri M., Kloog Y., Korczyn A.D., Ferdman-Aronovich R., Drory V., Katzav A., Wirguin I., Chapman J. Inhibition of Ras attenuates the course of experimental autoimmune neuritis. J. Neuroimmunol. 2005, 168:46-55.
15. Karussis D., Abramsky O., Grigoriadis N., Chapman J., Mizrachi-Koll R., Niv H., Kloog Y. The Ras-pathway inhibitor, S-trans-trans-farnesyl thiosalicylic acid, suppresses experimental allergic encephalomyelitis. J. Neuroimmunol. 2001, 120:1-9.
16. Katsura H., Obata K., Mizushima T., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Tokunaga A., Sakagami M., Noguchi K. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp. Neurol. 2006, 200:112-123.
17. Kaur G., Jaggi A.S., Singh N. Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in rats. J. Brachial. Plex. Peripher. Nerve Inj. 2010, 5:3.
18. Maher M., Ao H., Banke T., Nasser N., Wu N.T., Breitenbucher J.G., Chaplan S.R., Wickenden A.D. Activation of TRPA1 by farnesyl thiosalicylic acid. Mol. Pharmacol. 2008, 73:1225-1234.
19. Mao J., Price D.D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995, 61:353-364.
20. Marciano D., Ben-Baruch G., Marom M., Egozi Y., Haklai R., Kloog Y. Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth. J. Med. Chem. 1995, 38:1267-1272.
21. Marciano D., Shohami E., Kloog Y., Alexandrovitch A., Brandeis R., Goelman G. Neuroprotective effects of the Ras inhibitor S-trans-trans-farnesyl thiosalicylic acid, measured by diffusion-weighted imaging after traumatic brain injury in rats. J. Neurotrauma 2007, 24:1378-1386.
22. Marom M., Haklai R., Ben-Baruch G., Marciano D., Egozi Y., Kloog Y. Selective inhibition of Ras-dependent cell growth by farnesyl thiosalicylic acid. J. Biol. Chem. 1995, 270:22263-22270.
23. Mayer D.J., Mao J., Holt J., Price D.D. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc. Natl. Acad. Sci. USA 1999, 96:7731-7736.
24. McKemy D.D. How cold is it? TRPM8 and TRPA1 in the molecular logic of cold sensation. Mol. Pain 2005, 1:16.
25. Muthuraman A., Jaggi A.S., Singh N., Singh D. Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine-induced painful neuropathy in rats. Eur. J. Pharmacol. 2008, 587:104-111.
26. Norsted Gregory E., Codeluppi S., Gregory J.A., Steinauer J., Svensson C.I. Mammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammation. Neuroscience 2010, 169:1392-1402.
27. Pal P.K. Clinical and electrophysiological studies in vincristine induced neuropathy. Electromyogr. Clin. Neurophysiol. 1999, 39:323-330.
28. Ramer L.M., Borisoff J.F., Ramer M.S. Rho-kinase inhibition enhances axonal plasticity and attenuates cold hyperalgesia after dorsal rhizotomy. J. Neurosci. 2004, 24:10796-10805.
29. Shohami E., Yatsiv I., Alexandrovich A., Haklai R., Elad-Sfadia G., Grossman R., Biegon A., Kloog Y. The Ras inhibitor S-trans, trans-farnesyl thiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model. J. Cereb. Blood Flow Metab. 2003, 23:728-738.
30. Siau C., Bennett G.J. Dysregulation of neuronal calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth. Analg. 2006, 102:1485-1490.
31. Tatsumi S., Mabuchi T., Katano T., Matsumura S., Abe T., Hidaka H., Suzuki M., Sasaki Y., Minami T., Ito S. Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS). Neuroscience 2005, 131:491-498.
32. Tsuda M., Mizokoshi A., Shigemoto-Mogami Y., Koizumi S., Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004, 45:89-95.
33. Tumati S., Milnes T.L., Yamamura H.I., Vanderah T.W., Roeske W.R., Varga E.V. Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia. Eur. J. Pharmacol. 2008, 601:207-208.
34. Tumati S., Roeske W.R., Largent-Milnes T., Wang R., Vanderah T.W., Varga E.V. Sustained morphine-mediated pain sensitization and antinociceptive tolerance are blocked by intrathecal treatment with Raf-1-selective siRNA. Br. J. Pharmacol. 2010, 161:51-64.
35. Tumati S., Yamamura H.I., Vanderah T.W., Roeske W.R., Varga E.V. Sustained morphine treatment augments capsaicin-evoked calcitonin gene-related peptide release from primary sensory neurons in a protein kinase A- and Raf-1-dependent manner. J. Pharmacol. Exp. Ther. 2009, 330:810-817.
36. Wolf S., Barton D., Kottschade L., Grothey A., Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur. J. Cancer 2008, 44:1507-1515.
37. Yue X., Tumati S., Navratilova E., Strop D., St John P.A., Vanderah T.W., Roeske W.R., Yamamura H.I., Varga E.V. Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner. Eur. J. Pharmacol. 2008, 584:272-277.
38. Zhuang Z.Y., Gerner P., Woolf C.J., Ji R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 14:149-159.